Page last updated: 2024-10-25

cilostazol and Amnesia-Memory Loss

cilostazol has been researched along with Amnesia-Memory Loss in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Cilostazol (CSZ) has been shown to be a new treatment for cognitive impairment with limited efficacy."5.72Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. ( Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK, 2022)
"Cilostazol (CSZ) has been shown to be a new treatment for cognitive impairment with limited efficacy."1.72Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. ( Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gomaa, AA1
Farghaly, HSM1
Ahmed, AM1
El-Mokhtar, MA1
Hemida, FK1

Other Studies

1 other study available for cilostazol and Amnesia-Memory Loss

ArticleYear
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia.
    European journal of pharmacology, 2022, Apr-15, Volume: 921

    Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Caffeine; Cilostazol; Diabetes Mellitus,

2022